Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Brandes

Showing results (61-70 of 336) with videos related to

Pageof 34
Sort By:
Forum (Genoa, Italy)|January 21, 2004
Guidelines for the management and treatment of low-grade gliomasA A Brandes, A Tosoni, R D Kortmann
Chemical Reviews|February 16, 2007
New developments in the marine nitrogen cycleJay A Brandes, Allan H Devol, Curtis Deutsch
Future Oncology (London, England)|April 15, 2020
Immunotherapy in elderly patients: should we stay or should we go?Vincenzo Di Nunno, Enrico Franceschi, Alba A Brandes
Expert Review of Anticancer Therapy|July 13, 2002
Changing boundaries in the treatment of malignant gliomasA A Brandes, U Basso, L M Pasetto
Anticancer Research|August 6, 2000
New drugs in recurrent high grade gliomasA A Brandes, L M Pasetto, S Monfardini
Cancer Treatment Reviews|July 29, 2000
The treatment of cranial germ cell tumoursA A Brandes, L M Pasetto, S Monfardini
Anti-Cancer Drugs|April 11, 2000
Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine--a report of three casesA Brandes, U Reichmann, L Plasswilm, et al.
Expert Review of Anticancer Therapy|November 6, 2003
Medulloblastomas: do molecular and biologic markers indicate different prognoses and treatments?Alba A Brandes, Myriam K Paris, Umberto Basso
Molecular Biology and Evolution|June 23, 2001
Diversity, origin, and distribution of retrotransposons (gypsy and copia) in conifersN Friesen, A Brandes, J S Heslop-Harrison
Expert Opinion on Investigational Drugs|July 12, 2005
Novel therapeutics in adult malignant brain gliomasMichele Reni, Elena Mazza, Alicia Tosoni, et al.
Pageof 34

Showing results (61-70 of 336) with videos related to

Sort By:
Pageof 34
Forum (Genoa, Italy)|January 21, 2004
Guidelines for the management and treatment of low-grade gliomasA A Brandes, A Tosoni, R D Kortmann
Chemical Reviews|February 16, 2007
New developments in the marine nitrogen cycleJay A Brandes, Allan H Devol, Curtis Deutsch
Future Oncology (London, England)|April 15, 2020
Immunotherapy in elderly patients: should we stay or should we go?Vincenzo Di Nunno, Enrico Franceschi, Alba A Brandes
Expert Review of Anticancer Therapy|July 13, 2002
Changing boundaries in the treatment of malignant gliomasA A Brandes, U Basso, L M Pasetto
Anticancer Research|August 6, 2000
New drugs in recurrent high grade gliomasA A Brandes, L M Pasetto, S Monfardini
Cancer Treatment Reviews|July 29, 2000
The treatment of cranial germ cell tumoursA A Brandes, L M Pasetto, S Monfardini
Anti-Cancer Drugs|April 11, 2000
Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine--a report of three casesA Brandes, U Reichmann, L Plasswilm, et al.
Expert Review of Anticancer Therapy|November 6, 2003
Medulloblastomas: do molecular and biologic markers indicate different prognoses and treatments?Alba A Brandes, Myriam K Paris, Umberto Basso
Molecular Biology and Evolution|June 23, 2001
Diversity, origin, and distribution of retrotransposons (gypsy and copia) in conifersN Friesen, A Brandes, J S Heslop-Harrison
Expert Opinion on Investigational Drugs|July 12, 2005
Novel therapeutics in adult malignant brain gliomasMichele Reni, Elena Mazza, Alicia Tosoni, et al.
Pageof 34